Published in Clin Exp Immunol on August 01, 1976
Idiopathic paraproteinaemia. I. Studies in an animal model--the ageing C57BL/KaLwRij mouse. Clin Exp Immunol (1978) 1.48
B cell hyperactivity and abnormalities in T cell markers and immunoregulatory function in a patient with nucleoside phosphorylase deficiency. Clin Exp Immunol (1982) 0.87
Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome. Clin Exp Immunol (1984) 0.83
Wiskott-Aldrich syndrome: a multidisciplinary disease. J Clin Pathol (1991) 0.79
Monoclonal immunoglobulin-secreting lymphoma in a patient with severe combined immunodeficiency disease. Clin Exp Immunol (1982) 0.78
Systemic vasculitis and aneurysm formation in the Wiskott-Aldrich syndrome. J Clin Pathol (1999) 0.75
The progressive appearance of multiple urinary Bence-Jones proteins and serum paraproteins in a child with immune deficiency. Clin Exp Immunol (1979) 0.75
Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study. Immunology (1979) 0.75
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
Decline in suppressor T cell function with age in female NZB mice. J Immunol (1974) 2.79
The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet (1968) 2.61
Correlation of milk precipitins with IgA deficiency. N Engl J Med (1969) 2.28
Correlations between the concentrations of the four sub-classes of IgG and Gm Allotypes in normal human sera. J Immunol (1972) 1.96
IgG subclasses: development of the serum concentrations in "normal" infants and children. J Pediatr (1972) 1.59
Light chain typing of immunoglobulins in small samples of biological material. Immunology (1970) 1.56
Immunodeficiency disease and malignancy. Various immunologic deficiencies of man and the role of immune processes in the control of malignant disease. Ann Intern Med (1972) 1.34
Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry. Int J Cancer (1973) 1.34
Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism. J Clin Invest (1971) 1.05
Stability of human immunoglobulin levels. Proc Soc Exp Biol Med (1967) 1.03
Immunoglobulin levels as related to age in nonhuman primates in captivity. I. Chimpanzees. J Med Primatol (1974) 1.02
Quantitative estimation of human immunoglobulins. II. The development of serum immunoglobulin levels in man. J Hyg Epidemiol Microbiol Immunol (1970) 0.90
Immunoglobulin D (IgD) in childhood. I. Maturation of serum IgD: study of a population of healthy children. Biomedicine (1974) 0.88
Monoclonal gammopathy in the Wiskott-Aldrich syndrome. J Pediatr (1974) 0.88
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet (1981) 4.39
Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett (1985) 4.23
Metabolic properties of IgG subclasses in man. J Clin Invest (1970) 3.48
Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies. Scand J Immunol (1976) 2.78
Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol (1979) 2.60
A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry (1991) 2.60
Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics (1994) 2.33
Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J Exp Med (2000) 2.25
Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol (1986) 2.20
Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry (1992) 2.19
A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods (1994) 1.98
Correlations between the concentrations of the four sub-classes of IgG and Gm Allotypes in normal human sera. J Immunol (1972) 1.96
Prominence of IgG4 in the IgG antibody response to human filariasis. J Immunol (1985) 1.91
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int (1997) 1.88
DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nat Med (1998) 1.83
Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol (1985) 1.80
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol (1984) 1.78
Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer (1985) 1.74
Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med (1997) 1.64
Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry (1994) 1.60
IgG subclasses: development of the serum concentrations in "normal" infants and children. J Pediatr (1972) 1.59
Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics. Clin Immunol (1999) 1.57
A murine model of human myeloma bone disease. Bone (1997) 1.53
Biotyping of Enterobacteriaceae as a test for the evaluation of isolation systems. J Hyg (Lond) (1972) 1.50
Distribution of IgA subclasses in sera and bone marrow plasma cells of 21 normal individuals. Adv Exp Med Biol (1974) 1.48
Idiopathic paraproteinaemia. I. Studies in an animal model--the ageing C57BL/KaLwRij mouse. Clin Exp Immunol (1978) 1.48
Immunomodulation by intravenous immunoglobulin. Am J Pediatr Hematol Oncol (1990) 1.46
Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children. N Engl J Med (1990) 1.45
Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen. Infect Immun (1983) 1.44
Prediction of severe disseminated adenovirus infection by serum PCR. Lancet (2001) 1.44
IgG subclasses in viral infections. Monogr Allergy (1986) 1.42
Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr (1994) 1.42
Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients. Bone Marrow Transplant (2005) 1.41
Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol (1975) 1.41
Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease. Blood (1999) 1.40
[The stability of antibiotics administered in and with a parenteral nutrition mixture enriched with branched-chain amino acids. I. Amikacin and gentamycin]. Nutr Hosp (1993) 1.39
[Immunoglobulin substitution in the treatment of neonatal septicemia]. Schweiz Med Wochenschr (1981) 1.37
Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant (2003) 1.34
Reconventionalization following antibiotic decontamination in man and animals. Am J Clin Nutr (1977) 1.33
Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J Immunol Methods (1986) 1.32
Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int (1984) 1.32
Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene. Nucleic Acids Res (1987) 1.31
Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol (1993) 1.31
Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer (1997) 1.30
The quantification of human IgG subclasses in reference preparations. Clin Chim Acta (1985) 1.27
Metabolic properties of human IgA subclasses. Clin Exp Immunol (1973) 1.26
Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of the 2nd IUIS/WHO collaborative study. Immunol Lett (1992) 1.26
T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies. J Immunol (1981) 1.26
Animal model of human disease. Benign monoclonal gammopathy (idiopathic paraproteinemia). Am J Pathol (1981) 1.25
The 5TMM series: a useful in vivo mouse model of human multiple myeloma. Hematol J (2000) 1.25
Membrane-associated immunoglobulin determinants on bone marrow and blood lymphocytes in the pediatric age group and on fetal tissues. Ann N Y Acad Sci (1975) 1.24
Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med (1995) 1.24
Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection. J Virol (1997) 1.24
Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J Clin Immunol (1988) 1.24
Instability of the human immunoglobulin heavy chain constant region locus indicated by different inherited chromosomal deletions. Mol Biol Med (1983) 1.23
Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content. Vox Sang (1982) 1.23
The 5T2 mouse multiple myeloma model: characterization of 5T2 cells within the bone marrow. Br J Cancer (1987) 1.21
HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins. J Infect Dis (1986) 1.20
Long-term results of renal transplantation in children. Pediatrics (1978) 1.20
Characterization of the subclasses and light chain types of IgG antibodies to rubella. Clin Exp Immunol (1984) 1.16
Influence of light intensity on polymerization shrinkage and integrity of restoration-cavity interface. Eur J Oral Sci (1995) 1.14
Heterogeneity of erythrocyte catalase II. Isolation and characterization of normal and variant erythrocyte catalase and their subunits. Eur J Biochem (1974) 1.14
Idiopathic paraproteinemia--a consequence of an age-related deficiency in the T immune system. Three-stage development--a hypothesis. Clin Immunol Immunopathol (1979) 1.13
Human IgG subclasses in maternal and fetal serum. Vox Sang (1971) 1.12
Whole-blood lymphocyte cultures. J Immunol Methods (1989) 1.11
The origin of monomeric and polymeric forms of IgA in man. Adv Exp Med Biol (1974) 1.11
Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation (1990) 1.09
Intravenous immune globulin in symptomatic paediatric human immunodeficiency virus infection. Eur J Pediatr (1988) 1.09
High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J Virol (1997) 1.09
Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjögren's syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4. N Engl J Med (1985) 1.06
Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol (1991) 1.05
Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthritis Rheum (2007) 1.04
The effect of Gm(23) on the concentration of IgG2 and IgG4 in normal human serum. J Immunol (1973) 1.04
In vivo behaviour of gamma globulin preparations. Vox Sang (1980) 1.04
The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol (1988) 1.04
Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients. Clin Infect Dis (2002) 1.04
Idiopathic paraproteinemia. III. Increased frequency of paraproteinemia in thymectomized aging C57BL/KaLwRij and CBA/BrARij mice. J Immunol (1980) 1.04
Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant (2005) 1.04
Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunol Lett (1992) 1.03
IgG subclasses in human gamma-globulin preparations for intravenous use and their reactivity with staphylococcus protein A. Vox Sang (1980) 1.02
Increased frequency of homogeneous immunoglobulins in the sera of nude athymic mice with age. Clin Immunol Immunopathol (1980) 1.02
The G4 subclass in IgG fractions prepared by ion-exchange chromatography. J Immunol (1970) 1.02
Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A. Vox Sang (1982) 1.01
The differences in carbohydrate composition between the subclasses of IgA immunoglobulins. Immunochemistry (1976) 1.01
Aseptic necrosis after renal transplantation in children. Am J Dis Child (1978) 1.01